4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-20-018001
Chief Executive Officer acquired 273,058 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +41,016 | 41,016 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +122,601 | 122,601 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +13,671 | 13,671 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +13,671 | 13,671 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +50,712 | 91,728 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +3,394 | 17,065 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +3,394 | 17,065 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +21,695 | 113,423 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +1,452 | 18,517 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion | +1,452 | 18,517 | I | ||
| Derivatives | |||||||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series A Preferred Stock | −41,016 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series A Preferred Stock | −122,601 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series A Preferred Stock | −13,671 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series A Preferred Stock | −13,671 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series B-1 Preferred Stock | −50,712 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series B-1 Preferred Stock | −3,394 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series B-1 Preferred Stock | −3,394 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series B-2 Preferred Stock | −21,695 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series B-2 Preferred Stock | −1,452 | 0 | I | ||
| BLATT LAWRENCE Chief Executive Officer | 2020-10-20 | Conversion · Series B-2 Preferred Stock | −1,452 | 0 | I | ||
Loading xslF345X03/doc1.xml…